INTERNATIONAL PATENT: SHENCHUAN BIOTECHNOLOGY (SHANDONG) CO., LTD, 深川生物科技（山东）股份公司 FILES APPLICATION FOR "SINGLE-STRANDED NUCLEIC ACID OR DOUBLE-STRANDED NUCLEIC ACID AND USE THEREOF IN PREPARATION OF DRUG FOR TREATING DUCHENNE MUSCULAR DYSTROPHY"

Posted On: 2026-02-01

GENEVA, Feb. 1 -- SHENCHUAN BIOTECHNOLOGY (SHANDONG) CO., LTD (Room 123, Courtyard Office Building, No.149, Jiqi Road, Huaiyin DistrictJinan, Shandong 250000), 深川生物科技（山东）股份公司 (中国山东省济南市槐荫区济齐路149号大院办公楼123室) filed a patent application (PCT/CN2025/100558) for "SINGLE-STRANDED NUCLEIC ACID OR DOUBLE-STRANDED NUCLEIC ACID AND USE THEREOF IN PREPARATION OF DRUG FOR TREATING DUCHENNE MUSCULAR DYSTROPHY" on Jun 12, 2025. With publication no. WO/2026/021038, the details related to the patent application was pu...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SHENCHUAN BIOTECHNOLOGY (SHANDONG) CO., LTD, 深川生物科技（山东）股份公司 FILES APPLICATION FOR "SINGLE-STRANDED NUCLEIC ACID OR DOUBLE-STRANDED NUCLEIC ACID AND USE THEREOF IN PREPARATION OF DRUG FOR TREATING DUCHENNE MUSCULAR DYSTROPHY"